Company intelligence / Profile preview

Mobidiag

Ownership
Private
Employees
~250
Development stage
Commercial
01

Overview

Mobidiag has developed and commercialized molecular diagnostic platforms—Novodiag® for rapid multiplexed near-patient testing and Amplidiag® for high-throughput laboratory diagnostics. Their solutions enable fast identification of pathogens responsible for gastrointestinal, respiratory, healthcare-associated infections, sepsis, and antimicrobial resistance. The company was acquired by Hologic in June/July of 2021 for approximately €668 million (~$795 million). In calendar year 2020 they generated about $42 million in revenue. Their technologies are used across Europe with a focus on rapid turnaround times to improve patient care.

Therapeutic areas
Infectious Diseases
Modalities
Device (diagnostic platforms)Molecular diagnostics technology (qPCR and microarray-based assays)Not applicable for therapeutic modalities as the company focuses on diagnostics rather than therapeutics
Industry
Molecular Diagnostics
02

Partnerships

Unilabs agreement covering supply of Amplidiag products in Sweden/NorwayUniversity of Helsinki investment/collaboration

Beyond the preview

Go deeper on Mobidiag.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mobidiag.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call